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Introduction and aims: Despite major advances in coronary stent
technology, stent thrombosis (ST) remains a signiﬁcant complica-
tion of percutaneous coronary intervention (PCI) with a high rate of
MI and death, with multi-factorial underlying mechanisms. We
sought to study clinical and angiographic proﬁle of patients pre-
senting with deﬁnite ST to our Institute.
Methods: In this retrospective study, demographic and clinical
data were collected for patients presenting with deﬁnite ST to
our Institute over the past decade, and angiographic images of
samewere reviewed. LV systolic and diastolic functionwas studied
by 2D echocardiography and intracoronary thrombus was deﬁned
by angiography and graded as per standard systems. Details of PCI
done were also collected.
Results: A total of 53 patients (M = 34, F = 21) presented with
deﬁnite ST. Of the ST cases, 35.9% (n = 19) were acute (within
24 h, 11 were acute STEMI within 24 h), 56.6% (n = 30) sub-acute
(24 h–1 month), and 2 cases (3.7%), each classiﬁed as late (1–12
months) and very late (>1 year) after the initial PCI.10 patients
died either before treatment could be instituted (possible in 3,
probable in 2) or during PCI for ST (n = 5). Mean age of pre-
sentation was 49 years (range 34–72 years) and duration
of occurrence of ST ranged from ‘‘on table’’ immediately fol-
lowing stent deployment in 4 patients, to very late in 2
(mean = 34.5 days, median 207 days). Mean LVEF in ST group
was 35.5  5.5%.
The stent that had been implanted were: BMS in 25 patients, SES
in 17,and PES in 11 patients. The ST group had more smokers
(n = 32, 60.3%), more diabetics (n = 24, 45.2%), had h/o recent
STEMI, (n = 41, 77.4%) and 4 were loaded with clopidogrel after
the angiogram for an ad-hoc angioplasty procedure. Among the
patients with ST, nine had been given eptiﬁbatide after PCI, of
whom 4 developed ST despite the use of same. Acute ST during
primary PCI occurred in 5 patients (‘‘on-table’’) of whom 3 were
in cardiogenic shock with mean LVEF 30% and subsequently
died. As per artery involved LAD was most common (n = 37,
69.8% cases). In all cases but two, stent length was more than
18 mm. Of interest is that 5 ST patients had Hb <12 g% and could
be qualiﬁed as ‘‘anemic’’ by WHO standards, though this value
did not reach signiﬁcance in comparison with non-anemics who
developed ST.
Using univariate analysis, factors that were signiﬁcantly higher in
the ST groupwere noncompliance to DAPT use and/or interruption
of therapy in 8 patients for another procedure (10.4%), and PCI in
stenting for acute STEMI (with higher thrombus burden) in 11, with
severe LV dysfunction. Most stents deployed in ST population
measure >18 mm length (min = 10 mm, max = 33 mm). Presence
of cardiogenic shock in patients undergoing PCI was signiﬁcantly
associated with higher incidence of ST and mortality. Anemic
patients (even without requirement of blood transfusion) and
patients loaded ad-hoc for angioplasty showed a trend towards
higher ST. In terms of DAPT, 47 of the patients were on clopidogrel
and 7 on prasugrel. Use of ﬁrst-generation drug eluting stents v/s
BMS or thrombus aspiration was not associated with lower grades
of development of ST especially in acute setting. Interesting cases
included a 44 year-old male with ﬁrst presentation as ST and then
7 months later as type 4 ISR presenting as UA, and a 72 year man
with stent thrombosis of both LAD and RCA stents deployed in
same sitting for acute AWMI, who survived with immediate PCI to
both.
Conclusion: ST is a catastrophic phenomenon with high mortality
rates. Smokers, patients with lower Hb, diabetics with uncon-
trolled sugars, primary PCI in acute STEMI with severe LV dysfunc-
tion, longer stents more than 18 mm and noncompliance with
DAPT were all signiﬁcantly associated with higher ST events.
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Introduction: Despite restoration of epicardial coronary blood ﬂow
by pharmacologic or mechanical revascularization, myocardial
level reperfusion is not accomplished in many patients with ST
elevation myocardial infarction (STEMI) and is associated with
worse prognosis, this phenomenon is associated with microvas-
cular dysfunction which may occur secondary to epicardial pro-
cess or may be pre-existing or primary in nature. By studying
status of microcirculation in non infarct arteries we tried to ﬁnd
out whether microvascular dysfunction in setting of STEMI was
independent of the epicardial events.
Materials and methods: Patients with acute STEMI who received
thrombolysis and underwent coronary angiography (CAG) within
24 h of thrombolysis were included in the study as cases, non ACS
patients with normal coronary angiograms served as controls.
Corrected TIMI frame count and myocardial blush grading was
done in non infarct related vessels with no ﬂow limiting disease in
cases and for all vessels in controls. Myocardial blushwas assessed
in non infarct territory in cases. Comparison of CTFC between
cases and controls was done using standard statistical methods
to determine level of signiﬁcance in difference between cases and
controls.
Results: Mean overall CTFC in controls was 21.49 frames with a
standard deviation = 2.16, mean CTFC in controls for LAD, LCX and
RCA was 21.79, 22.52 and 20.65 respectively, mean overall CTFC in
cases was 23.545 frames with a standard deviation of 2.268, mean
CTFC in cases for LAD, LCX and RCA was 23.0, 24.1 and 23.2
respectively. p value of difference between mean CTFC in cases
and controls was <0.001 for LAD, LCX and RCA. There was a direct
correlation between number of risk factors and CTFC, r = 0.98,
p < 0.001 for both cases and controls
Discussion: Coronary ﬂow was signiﬁcantly slower in non infarct
related arteries in patients of STEMI as compared to controls. A
likely explanation could be that a primary transient or permanent
impairment of microcirculation may predispose a patient for epi-
cardial thrombus formation by causing slow ﬂow. Epicardial
thrombus in turn may lead to embolization of biologically active
atherothrombotic debris leading to furthermicrovascular dysfunc-
tion by clogging of microvessels or by causing inﬂammatory/
immunologic injury by biochemical mediators. Reperfusion injury
may come to play by causing vascular injury and may increase/
accelerate the microvascular dysfunction. Thus, a primary micro-
vascular dysfunction may be a causative factor not only for slow
ﬂow after revascularization but also may causative for occurrence
of STEMI itself.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 1 7 – s 4 8S34
